Uttar Pradesh Chief Minister Yogi Adityanath on Monday, 25 May 2026 congratulated Prof. Shyam Sundar, a renowned Kala-azar specialist from Uttar Pradesh, on being conferred the Padma Shri by President Draupadi Murmu at a ceremony in New Delhi for his outstanding contributions to medicine.

Context

In his post, CM Yogi described the honour as 'अत्यंत गौरव का विषय' ('a matter of immense pride'), noting that President Murmu personally conferred the award on Prof. Shyam Sundar for exceptional contributions in the field of medicine. He extended warm congratulations, calling the recognition 'the nation's respectful expression of your dedication, research, and spirit of service.'

The Padma Shri is India's fourth-highest civilian award, presented annually — a tradition that dates to 1954 — to recognise distinguished service across fields including science, medicine, and public health.

Policy Backdrop

Prof. Shyam Sundar, affiliated with Banaras Hindu University, is credited with pioneering the development of miltefosine — the first effective oral drug for visceral leishmaniasis, commonly known as Kala-azar — along with rapid diagnostic tests that transformed case detection in endemic regions. These breakthroughs have been foundational to India's national elimination efforts.

India's National Kala-azar Elimination Programme, integrated under the National Vector Borne Disease Control Programme since 2003, set successive elimination targets for 2015 and 2020, with miltefosine and rapid diagnostics forming the clinical backbone of the programme's case-management strategy. The disease remains endemic in parts of Bihar, Jharkhand, West Bengal, and Uttar Pradesh.

Stakeholders and Impact

Patients in Kala-azar-endemic districts are the most direct beneficiaries of Prof. Sundar's research: the shift from painful intravenous treatments to an oral regimen dramatically improved treatment adherence and access in remote, under-resourced communities. Medical researchers working on neglected tropical diseases also gain renewed visibility through such civilian recognition.

The Chief Minister's public acknowledgement signals the Uttar Pradesh government's intent to spotlight homegrown scientific achievement, reinforcing institutional pride around Banaras Hindu University as a centre of global-standard tropical-medicine research.

What's Next

Attention now turns to progress reports on remaining Kala-azar-endemic blocks across eastern India ahead of the next national elimination review. Sustained investment in rapid diagnostics and oral therapies — the pillars of Prof. Sundar's work — will be critical to crossing the elimination threshold. Any further Padma recognitions for public-health researchers in the current cycle are also being watched by the medical community.